These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 30222954)
1. Nicotine enhances alcoholic fatty liver in mice: Role of CYP2A5. Chen X; Owoseni E; Salamat J; Cederbaum AI; Lu Y Arch Biochem Biophys; 2018 Nov; 657():65-73. PubMed ID: 30222954 [TBL] [Abstract][Full Text] [Related]
2. Suppressed hepatocyte proliferation via a ROS-HNE-P21 pathway is associated with nicotine- and cotinine-enhanced alcoholic fatty liver in mice. Chen X; Wang K; Cederbaum AI; Lu Y Biochem Biophys Res Commun; 2019 Apr; 512(1):119-124. PubMed ID: 30876690 [TBL] [Abstract][Full Text] [Related]
3. Chronic Exposure to E-Cigarettes Elevates CYP2A5 Activity, Protein Expression, and Cotinine-Induced Production of Reactive Oxygen Species in Mice. Kanamori K; Ahmad SM; Hamid A; Lutfy K Drug Metab Dispos; 2024 Feb; 52(3):171-179. PubMed ID: 38195520 [TBL] [Abstract][Full Text] [Related]
4. Role of CYP2A5 in the clearance of nicotine and cotinine: insights from studies on a Cyp2a5-null mouse model. Zhou X; Zhuo X; Xie F; Kluetzman K; Shu YZ; Humphreys WG; Ding X J Pharmacol Exp Ther; 2010 Feb; 332(2):578-87. PubMed ID: 19923441 [TBL] [Abstract][Full Text] [Related]
5. Alcoholic fatty liver is enhanced in CYP2A5 knockout mice: The role of the PPARα-FGF21 axis. Chen X; Ward SC; Cederbaum AI; Xiong H; Lu Y Toxicology; 2017 Mar; 379():12-21. PubMed ID: 28131861 [TBL] [Abstract][Full Text] [Related]
7. Postnatal Smoke Exposure Further Increases the Hepatic Nicotine Metabolism in Prenatally Smoke Exposed Male Offspring and Is Linked with Aberrant Lkhagvadorj K; Zeng Z; Meyer KF; Verweij LP; Kooistra W; Reinders-Luinge M; Dijkhuizen HW; de Graaf IAM; Plösch T; Hylkema MN Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375250 [TBL] [Abstract][Full Text] [Related]
8. The role of CYP2A5 in liver injury and fibrosis: chemical-specific difference. Hong F; Si C; Gao P; Cederbaum AI; Xiong H; Lu Y Naunyn Schmiedebergs Arch Pharmacol; 2016 Jan; 389(1):33-43. PubMed ID: 26363552 [TBL] [Abstract][Full Text] [Related]
9. Nicotine metabolism and urinary elimination in mouse: in vitro and in vivo. Raunio H; Pokela N; Puhakainen K; Rahnasto M; Mauriala T; Auriola S; Juvonen RO Xenobiotica; 2008 Jan; 38(1):34-47. PubMed ID: 18098062 [TBL] [Abstract][Full Text] [Related]
10. Ethanol induction of CYP2A5: role of CYP2E1-ROS-Nrf2 pathway. Lu Y; Zhang XH; Cederbaum AI Toxicol Sci; 2012 Aug; 128(2):427-38. PubMed ID: 22552773 [TBL] [Abstract][Full Text] [Related]
11. Evidence for induced microsomal bilirubin degradation by cytochrome P450 2A5. Abu-Bakar A; Moore MR; Lang MA Biochem Pharmacol; 2005 Nov; 70(10):1527-35. PubMed ID: 16183037 [TBL] [Abstract][Full Text] [Related]
12. Alcoholic Liver Disease: from CYP2E1 to CYP2A5. Leung TM; Lu Y Curr Mol Pharmacol; 2017; 10(3):172-178. PubMed ID: 26278389 [TBL] [Abstract][Full Text] [Related]
13. Characterization and comparison of nicotine and cotinine metabolism in vitro and in vivo in DBA/2 and C57BL/6 mice. Siu EC; Tyndale RF Mol Pharmacol; 2007 Mar; 71(3):826-34. PubMed ID: 17158199 [TBL] [Abstract][Full Text] [Related]
14. Expression of cytochrome P450 2A5 in a glucose-6-phosphate dehydrogenase-deficient mouse model of oxidative stress. Nichols KD; Kirby GM Biochem Pharmacol; 2008 Mar; 75(5):1230-9. PubMed ID: 18068688 [TBL] [Abstract][Full Text] [Related]
15. Ethanol induction of CYP2A5: permissive role for CYP2E1. Lu Y; Zhuge J; Wu D; Cederbaum AI Drug Metab Dispos; 2011 Feb; 39(2):330-6. PubMed ID: 21051534 [TBL] [Abstract][Full Text] [Related]
16. Nicotine self-administration in mice is associated with rates of nicotine inactivation by CYP2A5. Siu EC; Wildenauer DB; Tyndale RF Psychopharmacology (Berl); 2006 Mar; 184(3-4):401-8. PubMed ID: 16485141 [TBL] [Abstract][Full Text] [Related]
17. High-fat diet induces fibrosis in mice lacking CYP2A5 and PPARα: a new model for steatohepatitis-associated fibrosis. Chen X; Acquaah-Mensah GK; Denning KL; Peterson JM; Wang K; Denvir J; Hong F; Cederbaum AI; Lu Y Am J Physiol Gastrointest Liver Physiol; 2020 Nov; 319(5):G626-G635. PubMed ID: 32877213 [TBL] [Abstract][Full Text] [Related]
18. Experimental nonalcoholic fatty liver disease in mice leads to cytochrome p450 2a5 upregulation through nuclear factor erythroid 2-like 2 translocation. Cui Y; Wang Q; Li X; Zhang X Redox Biol; 2013; 1(1):433-40. PubMed ID: 24191237 [TBL] [Abstract][Full Text] [Related]
19. Expression of cytochrome P450 2A5 in a C57BL/6J mouse model of nonalcoholic fatty liver disease. Li R; Guo G; Cao Y; Wang Y; Liu F; Zhang X Pharmacology; 2013; 92(1-2):26-31. PubMed ID: 23867551 [TBL] [Abstract][Full Text] [Related]
20. Interstrain differences in the expression and activity of Cyp2a5 in the mouse liver. Poça KS; Parente TE; Chagas LF; Leal BS; Leal HS; Paumgartten FJ; De-Oliveira AC BMC Res Notes; 2017 Mar; 10(1):125. PubMed ID: 28298240 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]